In Vitro Mucin Degradation and Paracellular Permeability by Fecal water from Crohn’s Disease Patients

References

• Wells JM, Brummer RJ, Derrien M et al. Homeostasis of the gut barrier and potential biomarkers. Am. J. Physiol. Gastrointest. Liver Physiol. 312(3), G171–G193 (2017).
   PubMed Web of Science ®Google Scholar
• Hsieh C-Y, Osaka T, Moriyama E, Date Y, Kikuchi J, Tsuneda S. Strengthening of the intestinal epithelial tight junction by Bifidobacterium bifidum . Physiol. Rep. 3(3), e12327 (2015).
   PubMedGoogle Scholar
• Wu S, Lim KC, Huang J, Saidi RF, Sears CL. Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin. Proc. Natl Acad. Sci. USA 95(25), 14979–14984 (1998).
   PubMed Web of Science ®Google Scholar
• Capaldo CT, Powell DN, Kalman D. Layered defense: how mucus and tight junctions seal the intestinal barrier. J. Mol. Med. 95(9), 927–934 (2017).
   PubMed Web of Science ®Google Scholar
• Buckley A, Turner JR. Cell biology of tight junction barrier regulation and mucosal disease. Cold Spring Harb. Perspect. Biol. 10(1), a029314 (2018).
   PubMed Web of Science ®Google Scholar
• Obiso RJ, Azghani AO, Wilkins TD. The Bacteroides fragilis toxin fragilysin disrupts the paracellular barrier of epithelial cells. Infect. Immun. 65(4), 1431–1439 (1997).
   PubMed Web of Science ®Google Scholar
• Eichner M, Protze J, Piontek A, Krause G, Piontek J. Targeting and alteration of tight junctions by bacteria and their virulence factors such as Clostridium perfringens enterotoxin. Pflugers Arch. Eur. J. Physiol. 469(1), 77–90 (2017).
   PubMed Web of Science ®Google Scholar
• Kaparakis-Liaskos M, Ferrero RL. Immune modulation by bacterial outer membrane vesicles. Nat. Rev. Immunol. 15(6), 375–387 (2015).
   PubMed Web of Science ®Google Scholar
• Zakharzhevskaya NB, Tsvetkov VB, Vanyushkina AA et al. Interaction of Bacteroides fragilis toxin with outer membrane vesicles reveals new mechanism of its secretion and delivery. Front. Cell. Infect. Microbiol. 7, 2 (2017).
   PubMed Web of Science ®Google Scholar
• Yan H, Ajuwon KM. Butyrate modifies intestinal barrier function in IPEC-J2 cells through a selective upregulation of tight junction proteins and activation of the Akt signaling pathway. PLOS ONE 12(6), e0179586 (2017).
   PubMed Web of Science ®Google Scholar
• Ma X, Fan PX, Li LS, Qiao SY, Zhang GL, Li DG. Butyrate promotes the recovering of intestinal wound healing through its positive effect on the tight junctions. J. Anim. Sci. 90(4), 266–268 (2012).
   PubMedGoogle Scholar
• Tong LC, Wang Y, Wang ZB et al. Propionate ameliorates dextran sodium sulfate-induced colitis by improving intestinal barrier function and reducing inflammation and oxidative stress. Front. Pharmacol. 7(Aug), 1–9 (2016).
   PubMedGoogle Scholar
• Baumgart DC, Sandborn WJ. Crohn’s disease. Lancet 380, 1590–1605 (2012).
   PubMed Web of Science ®Google Scholar
• Ahmed I, Roy B, Khan S, Septer S, Umar S. Microbiome, metabolome and inflammatory bowel disease. Microorganisms 4(2), 20 (2016).
   PubMed Web of Science ®Google Scholar
• Solberg IC, Vatn MH, Høie O et al. Clinical course in Crohn’s disease: results of a Norwegian population-based ten-year follow-up study. Clin. Gastroenterol. Hepatol. 5(12), 1430–1438 (2007).
   PubMed Web of Science ®Google Scholar
• Tedjo DI, Smolinska A, Savelkoul PH et al. The fecal microbiota as a biomarker for disease activity in Crohn’s disease. Sci. Rep. 6, 1–10 (2016).
   PubMed Web of Science ®Google Scholar
• Galazzo G, Tedjo DI, Wintjens DSJ et al. Faecal microbiota dynamics and their relation to disease course in Crohn’s disease. J. Crohn’s Colitis. 13(10), 1273–1282 (2019).
   Google Scholar
• Joossens M, Huys G, Cnockaert M et al. Dysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives. Gut 60, 631–637 (2011).
   PubMed Web of Science ®Google Scholar
• Pascal V, Pozuelo M, Borruel N et al. A microbial signature for Crohn’s disease. Gut 66(5), 813–822 (2017).
   PubMed Web of Science ®Google Scholar
• Zeissig S, Bürgel N, Günzel D et al. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn’s disease. Gut 56(1), 61–72 (2007).
   PubMed Web of Science ®Google Scholar
• van den Heuvel T, Jonkers D, Jeuring S et al. Cohort profile: the Inflammatory Bowel Disease South Limburg Cohort (IBDSL). Int. J. Epidemiol. 46(2), e7 (2017).
   PubMed Web of Science ®Google Scholar
• Koutroumpakis E, Katsanos K. Implementation of the simple endoscopic activity score in Crohn’s disease. Saudi J. Gastroenterol. 22(3), 183–191 (2016).
   PubMed Web of Science ®Google Scholar
• Marchesi JR, Holmes E, Khan F et al. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J. Proteome Res. 6(2), 546–551 (2007).
   PubMed Web of Science ®Google Scholar
• Benedikter BJ, Bouwman FG, Vajen T et al. Ultrafiltration combined with size exclusion chromatography efficiently isolates extracellular vesicles from cell culture media for compositional and functional studies. Sci. Rep. 7(1), 15297 (2017).
   PubMed Web of Science ®Google Scholar
• Abe F, Muto M, Yaeshima T et al. Safety evaluation of probiotic bifidobacteria by analysis of mucin degradation activity and translocation ability. Anaerobe 16(2), 131–136 (2010).
   PubMed Web of Science ®Google Scholar
• Srinivasan B, Kolli AR, Esch MB, Abaci HE, Shuler ML, Hickman JJ. TEER measurement techniques for in vitro barrier model systems. J. Lab. Autom. 20(2), 107–26 (2015).
   PubMedGoogle Scholar
• Elamin E, Jonkers D, Juuti-Uusitalo K et al. Effects of ethanol and acetaldehyde on tight junction integrity: in vitro study in a three dimensional intestinal epithelial cell culture model. PLOS ONE 7(4), e35008 (2012).
   PubMed Web of Science ®Google Scholar
• Becker HEF, Jamin C, Bervoets L et al. Higher prevalence of Bacteroides fragilis in Crohn’s disease exacerbations and strain-dependent increase of epithelial resistance. Front. Microbiol. 12, 1–13 (2021).
   Web of Science ®Google Scholar
• Caporaso JG, Lauber CL, Walters WA et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J. 6, 1621–1624 (2012).
   PubMed Web of Science ®Google Scholar
• Lagkouvardos I, Joseph D, Kapfhammer M et al. IMNGS: a comprehensive open resource of processed 16S rRNA microbial profiles for ecology and diversity studies. Sci. Rep. 6(April), 1–9 (2016).
   PubMedGoogle Scholar
• Edgar RC. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat. Methods 10(10), 996–998 (2013).
   PubMed Web of Science ®Google Scholar
• Edgar R. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26(19), 2460–1 (2010).
   PubMed Web of Science ®Google Scholar
• Edgar R, Haas B, Clemente J, Quince C, Knight R. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27(16), 2194–200 (2011).
   PubMed Web of Science ®Google Scholar
• Wang Q, Garrity G, Tiedje J, Cole J. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 73(16), 5261–7 (2007).
   PubMed Web of Science ®Google Scholar
• Edgar R. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32(5), 1792–1797 (2004).
   PubMed Web of Science ®Google Scholar
• Price M, Dehal P, Arkin A. FastTree 2 – approximately maximum-likelihood trees for large alignments. PLOS ONE 5(3), e9490 (2010).
   PubMed Web of Science ®Google Scholar
• Yuan L, van der Mei HC, Busscher HJ, Peterson BW. Two-stage interpretation of changes in TEER of intestinal epithelial layers protected by adhering Bifidobacteria during E. coli challenges. Front. Microbiol. 11, doi: 10.3389/fmicb.2020.599555 (2020).
   Web of Science ®Google Scholar
• Kameli N, Becker HEF, Welbers T et al. Metagenomic profiling of fecal-derived bacterial membrane vesicles in Crohn’s disease patients. Cells 10(2795), 1–16 (2021).
   Google Scholar
• Santoru ML, Piras C, Murgia A et al. Cross sectional evaluation of the gut-microbiome metabolome axis in an Italian cohort of IBD patients. Sci. Rep. 7(1), 1–14 (2017).
   PubMedGoogle Scholar
• Stentz R, Carvalho AL, Jones EJ, Carding SR. Fantastic voyage: the journey of intestinal microbiota-derived microvesicles through the body. Biochem. Soc. Trans. 46(5), 1021–1027 (2018).
   PubMedGoogle Scholar
• Turner B, Bhaskar K, Hadzopoulou-Cladaras M, LaMont J. Cysteine-rich regions of pig gastric mucin contain von Willebrand factor and cystine knot domains at the carboxyl terminal(1). Biochim. Biophys. Acta 1447(1), 77–92 (1999).
   PubMedGoogle Scholar
• Johansson MEV, Sjövall H, Hansson GC. The gastrointestinal mucus system in health and disease. Nat. Rev. Gastroenterol. Hepatol. 10(6), 352–361 (2013).
   PubMed Web of Science ®Google Scholar
• Zhou JS, Gopal PK, Gill HS. Potential probiotic lactic acid bacteria Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019) do not degrade gastric mucin in vitro . Int. J. Food Microbiol. 63(1–2), 81–90 (2001).
   PubMed Web of Science ®Google Scholar
• Sicard J-F, Le Bihan G, Vogeleer P, Jacques M, Harel J. Interactions of intestinal bacteria with components of the intestinal mucus. Front. Cell. Infect. Microbiol. 7, 387 (2017).
   PubMed Web of Science ®Google Scholar
• Sun J, Shen X, Li Y et al. Therapeutic potential to modify the mucus barrier in inflammatory bowel disease. Nutrients 8(1), 44 (2016).
   PubMed Web of Science ®Google Scholar
• Verma R, Verma AK, Ahuja V, Paul J. Real-time analysis of mucosal flora in patients with inflammatory bowel disease in India. J. Clin. Microbiol. 48(11), 4279–4282 (2010).
   PubMed Web of Science ®Google Scholar
• Ijssennagger N, van der Meer R, van Mil SWC. Sulfide as a mucus barrier-breaker in inflammatory bowel disease? Trends Mol. Med. 22(3), 190–199 (2016).
   PubMed Web of Science ®Google Scholar
• Flint HJ, Scott KP, Duncan SH, Louis P, Forano E. Microbial degradation of complex carbohydrates in the gut. Gut Microbes 3(4), 289–306 (2012).
   PubMed Web of Science ®Google Scholar
• Png CW, Lindén SK, Gilshenan KS et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am. J. Gastroenterol. 105, 2420–2428 (2010).
   PubMed Web of Science ®Google Scholar
• Ungaro F, Massimino L, Alessio SD, Danese S. The gut virome in inflammatory bowel disease pathogenesis: from metagenomics to novel therapeutic approaches. United Eur. Gastroenterol. J. 7(8), 999–1007 (2019).
   PubMed Web of Science ®Google Scholar
• de Graaf MCG, Spooren CEGM, Hendrix EMB et al. Diet quality and dietary inflammatory index in dutch inflammatory bowel disease and irritable bowel syndrome patients. Nutrient 14, 1945 (2022).
   PubMedGoogle Scholar
• Balestrieri P, Ribolsi M, Guarino MPL, Emerenziani S, Altomare A, Cicala M. Nutritional aspects in inflammatory bowel diseases. Nutrients 12(2), 372 (2020).
   PubMed Web of Science ®Google Scholar
• Delgado ME, Grabinger T, Brunner T. Cell death at the intestinal epithelial front line. FEBS J. 283, 2701–2719 (2016).
   PubMed Web of Science ®Google Scholar
• Bruininx EMAM, Koninkx JFJG, Binnendijk GP et al. Effects of prefermented cereals or the end products of fermentation on growth and metabolism of enterocyte-like Caco-2 cells and on intestinal health of restrictedly fed weanling pigs. Animal 4(1), 40–51 (2010).
   PubMed Web of Science ®Google Scholar
• Zhu L, Han J, Li L, Wang Y, Li Y, Zhang S. Claudin family participates in the pathogenesis of inflammatory bowel diseases and colitis-associated colorectal cancer. Front. Immunol. 10, 1–11 (2019).
   PubMed Web of Science ®Google Scholar
• Xu P, Becker H, Elizalde M, Masclee A, Jonkers D. Intestinal organoid culture model is a valuable system to study epithelial barrier function in IBD. Gut 67(10), 1905–1906 (2018).
   PubMed Web of Science ®Google Scholar